Presage Biosciences
Pre-clinicalUsing Presage's patented CIVO (Comparative In Vivo Oncology) platform, tumor microenvironment response to multiple investigational treatments, alone or in combination, can be observed where it matters most—in a patient's tumor.
Founded
2007
Focus
OncologyDrug Delivery
About
Using Presage's patented CIVO (Comparative In Vivo Oncology) platform, tumor microenvironment response to multiple investigational treatments, alone or in combination, can be observed where it matters most—in a patient's tumor.
Funding History
3Total raised: $56M
Series C$26MThe Column GroupOct 15, 2018
Series B$20MThe Column GroupJun 15, 2016
Series A$10MThe Column GroupJan 15, 2014
Company Info
TypePrivate
Founded2007
LocationSeattle, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile